NM_001242896.3:c.3461C>T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001242896.3(DEPDC5):​c.3461C>T​(p.Ser1154Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000878 in 1,583,666 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000094 ( 0 hom. )

Consequence

DEPDC5
NM_001242896.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:7O:1

Conservation

PhyloP100: 0.982

Publications

5 publications found
Variant links:
Genes affected
DEPDC5 (HGNC:18423): (DEP domain containing 5, GATOR1 subcomplex subunit) This gene encodes a member of the IML1 family of proteins involved in G-protein signaling pathways. The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates cell growth by sensing the availability of nutrients. The protein encoded by this gene is a component of the GATOR1 (GAP activity toward Rags) complex which inhibits the amino acid-sensing branch of the mTORC1 pathway. Mutations in this gene are associated with autosomal dominant familial focal epilepsy with variable foci. A single nucleotide polymorphism in an intron of this gene has been associated with an increased risk of hepatocellular carcinoma in individuals with chronic hepatitis C virus infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
DEPDC5 Gene-Disease associations (from GenCC):
  • epilepsy, familial focal, with variable foci 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, Illumina, G2P
  • focal epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant epilepsy with auditory features
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial focal epilepsy with variable foci
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Brugada syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06171015).
BS2
High AC in GnomAdExome4 at 135 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DEPDC5NM_001242896.3 linkc.3461C>T p.Ser1154Phe missense_variant Exon 34 of 43 ENST00000651528.2 NP_001229825.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DEPDC5ENST00000651528.2 linkc.3461C>T p.Ser1154Phe missense_variant Exon 34 of 43 NM_001242896.3 ENSP00000498382.1
ENSG00000285404ENST00000646701.1 linkc.1786+51495C>T intron_variant Intron 20 of 20 ENSP00000496158.1

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152162
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000816
AC:
18
AN:
220714
AF XY:
0.0000416
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000363
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000164
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000943
AC:
135
AN:
1431504
Hom.:
0
Cov.:
31
AF XY:
0.0000984
AC XY:
70
AN XY:
711586
show subpopulations
African (AFR)
AF:
0.0000313
AC:
1
AN:
31908
American (AMR)
AF:
0.00
AC:
0
AN:
38756
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24964
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37586
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80948
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53008
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5664
European-Non Finnish (NFE)
AF:
0.000118
AC:
130
AN:
1099604
Other (OTH)
AF:
0.0000677
AC:
4
AN:
59066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152162
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41444
American (AMR)
AF:
0.00
AC:
0
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000154
Hom.:
0
Bravo
AF:
0.0000491
ExAC
AF:
0.0000414
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:4
Feb 01, 2019
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Uncertain:1
Mar 01, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: DEPDC5 c.3461C>T (p.Ser1154Phe) results in a non-conservative amino acid change in the encoded protein sequence. Three of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8.2e-05 in 220714 control chromosomes. c.3461C>T has been reported in the literature in three individuals from one family, among whom, one individual was affected with Temporal Lobe Epilepsy, the second individual was noted with unclassified phenotype, and the third individual was reported to be unaffected (Ricos_2016). These report(s) do not provide unequivocal conclusions about association of the variant with Epilepsy, Familial Focal, With Variable Foci 1. At least one publication reports experimental evidence evaluating an impact on protein function. These results showed no damaging effect of this variant by measuring the DEPDC5 expression and the affect on mTORC1 activity (Dawson_2019). The following publications have been ascertained in the context of this evaluation (PMID: 27208208, 31639411, 26505888). ClinVar contains an entry for this variant (Variation ID: 264763). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Familial focal epilepsy with variable foci Uncertain:1
Oct 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 1154 of the DEPDC5 protein (p.Ser1154Phe). This variant is present in population databases (rs578244490, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of DEPDC5-related conditions (PMID: 26505888). ClinVar contains an entry for this variant (Variation ID: 264763). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this missense change does not substantially affect DEPDC5 function (PMID: 31639411). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

DEPDC5-related disorder Uncertain:1
Jan 31, 2023
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The DEPDC5 c.3461C>T variant is predicted to result in the amino acid substitution p.Ser1154Phe. This variant was reported in an family with epilepsy, however the variant did not segregate with the disease completely (Ricos et al. 2016. PubMed ID: 26505888 Figure 2). Functional studies show that this variant does not significantly affect the protein function (Dawson et al. 2019. PubMed ID: 31639411). This variant is reported in 0.015% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/22-32266706-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Epilepsy, familial focal, with variable foci 1 Other:1
-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.015
.;.;.;.;.;T;.;.;.;.;T;.;.;.;.
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.21
FATHMM_MKL
Benign
0.34
N
LIST_S2
Uncertain
0.90
D;D;D;D;D;D;.;.;D;D;.;D;.;D;D
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.062
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.34
.;.;.;.;.;N;.;.;.;.;N;.;.;N;.
PhyloP100
0.98
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.51
N;.;.;.;.;N;N;.;.;.;N;.;N;N;.
REVEL
Benign
0.025
Sift
Benign
0.32
T;.;.;.;.;D;T;.;.;.;T;.;T;T;.
Sift4G
Benign
0.53
T;.;.;.;.;.;T;.;.;.;T;.;.;T;.
Polyphen
0.37
.;.;B;.;.;.;.;.;.;.;.;.;B;.;.
Vest4
0.17
MVP
0.11
MPC
0.50
ClinPred
0.048
T
GERP RS
3.8
Varity_R
0.048
Mutation Taster
=0/100
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs578244490; hg19: chr22-32266706; COSMIC: COSV56697540; COSMIC: COSV56697540; API